Planning target volume and dose prescription in definitive radiotherapy for prostate cancer with favourable prognostic factors.
Wachter
Stefan
S
Department of Radiotherapy and Radiobiology, University Hospital, Vienna, Austria. stefan.wachter@akh-wien.ac.at
Gerstner
Natascha
N
Mock
Ulrike
U
Pötter
Richard
R
D000230:Adenocarcinoma / Q000097:blood / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000532:radiotherapy*; D000951:Antigens, Neoplasm / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood; D006801:Humans; D007390:International Agencies; D008207:Lymphatic Metastasis; D008279:Magnetic Resonance Imaging; D008297:Male; D017410:Practice Guidelines as Topic; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D020266:Radiotherapy, Conformal / Q000379:methods*; D012307:Risk Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen